Tema ETFs’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.22M Buy
57,158
+415
+0.7% +$54.7K 0.23% 89
2026
Q1
$7.91M Sell
56,743
-1,371
-2% -$192K 0.53% 57
2025
Q4
$7.13M Sell
58,114
-3,326
-5% -$404K 0.55% 50
2025
Q3
$6.82M Buy
61,440
+25,912
+73% +$2.95M 0.57% 42
2025
Q2
$3.94M Sell
35,528
-3,094
-8% -$329K 1.05% 30
2025
Q1
$4.33M Buy
38,622
+7,776
+25% +$802K 1.29% 19
2024
Q4
$2.85M Buy
+30,846
New +$2.78M 1.18% 28

Other funds holding GILD

Tema ETFs's GILD Position: Q2 2026 in Review

Tema ETFs increased its Gilead Sciences (GILD) stake by 0.73% in Q2 2026, buying an estimated $54.7K and bringing the position to 57,158 shares worth $7.22M. The position accounts for 0.23% of the portfolio, ranked #89.

Tema ETFs first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.91M in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tema ETFs held 57,158 shares of Gilead Sciences worth $7.22M as of Q2 2026.
  • Tema ETFs bought 415 Gilead Sciences shares in Q2 2026, an estimated $54.7K.
  • Gilead Sciences made up 0.23% of Tema ETFs's portfolio in Q2 2026, its #89 holding.
  • Tema ETFs first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Tema ETFs's Gilead Sciences position peaked at $7.91M in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.